ERVH48-1 and Down syndrome: When the same quantitative SUPYN ELISA was used to compare maternal serum from women at 16–20 weeks gestation with pregnancies affected by Down syndrome to gestational age-matched women with unaffected (disomic) pregnancies, we detected higher levels of SUPYN protein in the mothers carrying a baby with TS21 (Fig. 2b).